Environmental risk factors and asthma primary prevention: From birth cohort studies to clinical trials

Amy A Eapen1, Soni Shankhwar2, Erika von Mutius3

  • 1Division of Allergy and Clinical Immunology, Department of Internal Medicine, Henry Ford Health + Michigan State University Health Sciences Center, Detroit, Mich.

Insights

Birth cohort studies are crucial for understanding how early life environmental exposures impact pediatric asthma and allergy development. Research guides interventions to optimize immune development and prevent allergic diseases.

Area of Science:

  • Environmental Epidemiology
  • Pediatric Allergy and Immunology
  • Developmental Origins of Health and Disease

Background:

  • Rising prevalence of pediatric asthma and allergic diseases since the mid-20th century.
  • Need to identify prenatal and early life environmental factors influencing disease risk.
  • Importance of understanding biologic mechanisms for targeted interventions.

Purpose of the Study:

  • Review the role of birth cohort studies in childhood asthma and allergy research.
  • Examine how these studies inform clinical trials for prevention.
  • Identify knowledge gaps and future research directions.

Main Methods:

  • Literature review of birth cohort studies.
  • Analysis of environmental epidemiology and etiology findings.
  • Assessment of study impact on clinical trial design.

Main Results:

  • Birth cohort studies have been pivotal in identifying environmental risk factors.
  • Findings have elucidated biologic mechanisms underlying allergic diseases.
  • These studies guide current asthma and allergy prevention strategies.

Conclusions:

  • Birth cohort studies are essential for understanding childhood-onset asthma and allergies.
  • Continued research is needed to address remaining questions in prevention.
  • Future approaches should focus on filling knowledge gaps for optimized interventions.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
606
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K